Skip to main content
Melissa Geller, MD, Obstetrics & Gynecology, Minneapolis, MN, M Health Fairview University of Minnesota Medical Center

MelissaAnnGellerMD

Obstetrics & Gynecology Minneapolis, MN

Gynecologic Oncology

Professor, Obstetrics & Gynecology, University of Minnesota Medical School Division of Gynecologic Oncology

Telehealth Available

Overview of Dr. Geller

Dr. Melissa Geller is an obstetrician/gynecologist in Minneapolis, MN and is affiliated with multiple hospitals in the area, including University of Minnesota, Regions Hospital, Park Nicollet Methodist Hospital, St. Cloud Veterans Affairs Health Care System, and Fairview Lakes Health Services. She received her medical degree from Chicago Medical School/Rosalind Franklin University of Medicine Science and has been in practice 19 years. She specializes in gynecologic oncology and is experienced in general obstetrics and gynecology, hysterectomy, and gynecologic oncology.

Education & Training

  • University of Minnesota
    University of MinnesotaResidency, Obstetrics and Gynecology, 1998 - 2002
  • Chicago Medical School at Rosalind Franklin University of Medicine and Science
    Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1998

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2023 - 2025
  • MN State Medical License
    MN State Medical License 2002 - 2024
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • HCW Biologics : Masonic Cancer Center at the University of Minnesota Receives FDA Clearance to Proceed with Phase 1 Clinical Trial in Solid Tumors for HCW9218, HCW Biologics' Novel Bifunctional Fusion Protein - Form 8-K
    HCW Biologics : Masonic Cancer Center at the University of Minnesota Receives FDA Clearance to Proceed with Phase 1 Clinical Trial in Solid Tumors for HCW9218, HCW Biologics' Novel Bifunctional Fusion Protein - Form 8-KJanuary 26th, 2022
  • The High Difficulty of Diagnosing Ovarian Cancer
    The High Difficulty of Diagnosing Ovarian CancerDecember 1st, 2015
  • MOCA Fundraising Fuels 'U' Ovarian Cancer Research
    MOCA Fundraising Fuels 'U' Ovarian Cancer ResearchNovember 30th, 2015

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Illinois PPO
    BCBS Minnesota Blue Cross Accord
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    First Health PPO
    GHI PPO
    Great West PPO
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    MagnaCare PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Oxford Health Freedom
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
    WEA Trust Preferred Provider Plan - Trust Pref
  • Please verify your coverage with the provider's office directly when scheduling an appointment